Digestive Health Specialists, PA

Tupelo, Mississippi 38801

0 studies enrolling now · 11 studies all time

What they study most

Adenomatous Polyps, Clostridium Infections, Colitis, Ulcerative, Colorectal Cancer, Diarrhea, Hepatitis C, Hepatitis C, Chronic, Irritable Bowel Syndrome, Opioid-Induced Bowel Dysfunction, Primary Biliary Cholangitis, Ulcerative Colitis

Studies at this site

• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA) — Completed
• Chemoprevention of Colorectal Adenomas — Stopped early
• Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone — Completed
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed
• A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) — Completed
• Genetic Study of Young Patients With Colorectal Cancer — Completed
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients — Completed
• Phase 3 Study of Sofosbuvir and Ribavirin — Completed
• Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection — Completed
• A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C — Completed
• CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission — Completed